New Results
Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Cyril Planchais, Ignacio Fernández, Timothée Bruel, Guilherme Dias de Melo, Matthieu Prot, Maxime Beretta, Pablo Guardado-Calvo, Jérémy Dufloo, Luis M. Molinos-Albert, Marija Backovic, Jeanne Chiaravalli, Emilie Giraud, Benjamin Vesin, Laurine Conquet, Ludivine Grzelak, Delphine Planas, Isabelle Staropoli, Florence Guivel-Benhassine, Mikaël Boullé, Minerva Cervantes-Gonzalez, French COVID Cohort Study Group, CORSER Study Group, Marie-Noëlle Ungeheuer, Pierre Charneau, Sylvie van der Werf, Fabrice Agou, Jordan D. Dimitrov, Etienne Simon-Lorière, Hervé Bourhy, Xavier Montagutelli, Félix A. Rey, Olivier Schwartz, View ORCID ProfileHugo Mouquet
doi: https://doi.org/10.1101/2022.04.01.486719
Cyril Planchais
1Institut Pasteur, Université Paris Cité, Laboratory of Humoral Immunology, F-75015 Paris, France
2INSERM U1222, F-75015 Paris, France
Ignacio Fernández
3Institut Pasteur, Université Paris Cité, Structural Virology Unit, F-75015 Paris, France
4CNRS UMR3569, F-75015 Paris, France
Timothée Bruel
4CNRS UMR3569, F-75015 Paris, France
5Institut Pasteur, Université Paris Cité, Virus & Immunity Unit, F-75015 Paris, France
Guilherme Dias de Melo
6Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, F-75015 Paris, France
Matthieu Prot
7Institut Pasteur, Université Paris Cité, G5 Evolutionary Genomics of RNA Viruses, F-75015 Paris, France
Maxime Beretta
1Institut Pasteur, Université Paris Cité, Laboratory of Humoral Immunology, F-75015 Paris, France
2INSERM U1222, F-75015 Paris, France
Pablo Guardado-Calvo
3Institut Pasteur, Université Paris Cité, Structural Virology Unit, F-75015 Paris, France
4CNRS UMR3569, F-75015 Paris, France
Jérémy Dufloo
4CNRS UMR3569, F-75015 Paris, France
5Institut Pasteur, Université Paris Cité, Virus & Immunity Unit, F-75015 Paris, France
Luis M. Molinos-Albert
1Institut Pasteur, Université Paris Cité, Laboratory of Humoral Immunology, F-75015 Paris, France
2INSERM U1222, F-75015 Paris, France
Marija Backovic
3Institut Pasteur, Université Paris Cité, Structural Virology Unit, F-75015 Paris, France
4CNRS UMR3569, F-75015 Paris, France
Jeanne Chiaravalli
8Institut Pasteur, Université Paris Cité, Chemogenomic and Biological Screening Core Facility, C2RT, F-75015 Paris, France
Emilie Giraud
8Institut Pasteur, Université Paris Cité, Chemogenomic and Biological Screening Core Facility, C2RT, F-75015 Paris, France
Benjamin Vesin
9Pasteur-TheraVectys, F-75015 Paris, France
10Institut Pasteur, Université Paris Cité, Molecular Virology & Vaccinology Unit, F-75015 Paris, France
Laurine Conquet
11Institut Pasteur, Université Paris Cité, Mouse Genetics Laboratory, F-75015 Paris, France
Ludivine Grzelak
4CNRS UMR3569, F-75015 Paris, France
5Institut Pasteur, Université Paris Cité, Virus & Immunity Unit, F-75015 Paris, France
Delphine Planas
4CNRS UMR3569, F-75015 Paris, France
5Institut Pasteur, Université Paris Cité, Virus & Immunity Unit, F-75015 Paris, France
Isabelle Staropoli
4CNRS UMR3569, F-75015 Paris, France
5Institut Pasteur, Université Paris Cité, Virus & Immunity Unit, F-75015 Paris, France
Florence Guivel-Benhassine
4CNRS UMR3569, F-75015 Paris, France
5Institut Pasteur, Université Paris Cité, Virus & Immunity Unit, F-75015 Paris, France
Mikaël Boullé
8Institut Pasteur, Université Paris Cité, Chemogenomic and Biological Screening Core Facility, C2RT, F-75015 Paris, France
Minerva Cervantes-Gonzalez
12Department of Epidemiology, Biostatistics and Clinical Research, Assistance Publique-Hôpitaux de Paris, Bichat Claude Bernard University Hospital, INSERM CIC-EC 1425, Paris, France
Marie-Noëlle Ungeheuer
13Institut Pasteur, Université Paris Cité, Investigation Clinique et Accès aux Ressources Biologiques (ICAReB), Center for Translational Research, F-75015 Paris, France
Pierre Charneau
9Pasteur-TheraVectys, F-75015 Paris, France
10Institut Pasteur, Université Paris Cité, Molecular Virology & Vaccinology Unit, F-75015 Paris, France
Sylvie van der Werf
4CNRS UMR3569, F-75015 Paris, France
14Institut Pasteur, Université Paris Cité, Molecular Genetics of RNA Viruses, F-75015 Paris, France
15Université de Paris, Paris, France
Fabrice Agou
8Institut Pasteur, Université Paris Cité, Chemogenomic and Biological Screening Core Facility, C2RT, F-75015 Paris, France
Jordan D. Dimitrov
16Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, 75006 Paris, France
Etienne Simon-Lorière
7Institut Pasteur, Université Paris Cité, G5 Evolutionary Genomics of RNA Viruses, F-75015 Paris, France
Hervé Bourhy
6Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, F-75015 Paris, France
Xavier Montagutelli
11Institut Pasteur, Université Paris Cité, Mouse Genetics Laboratory, F-75015 Paris, France
Félix A. Rey
3Institut Pasteur, Université Paris Cité, Structural Virology Unit, F-75015 Paris, France
4CNRS UMR3569, F-75015 Paris, France
Olivier Schwartz
4CNRS UMR3569, F-75015 Paris, France
5Institut Pasteur, Université Paris Cité, Virus & Immunity Unit, F-75015 Paris, France
Hugo Mouquet
1Institut Pasteur, Université Paris Cité, Laboratory of Humoral Immunology, F-75015 Paris, France
2INSERM U1222, F-75015 Paris, France
Article usage
Posted April 01, 2022.
Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Cyril Planchais, Ignacio Fernández, Timothée Bruel, Guilherme Dias de Melo, Matthieu Prot, Maxime Beretta, Pablo Guardado-Calvo, Jérémy Dufloo, Luis M. Molinos-Albert, Marija Backovic, Jeanne Chiaravalli, Emilie Giraud, Benjamin Vesin, Laurine Conquet, Ludivine Grzelak, Delphine Planas, Isabelle Staropoli, Florence Guivel-Benhassine, Mikaël Boullé, Minerva Cervantes-Gonzalez, French COVID Cohort Study Group, CORSER Study Group, Marie-Noëlle Ungeheuer, Pierre Charneau, Sylvie van der Werf, Fabrice Agou, Jordan D. Dimitrov, Etienne Simon-Lorière, Hervé Bourhy, Xavier Montagutelli, Félix A. Rey, Olivier Schwartz, Hugo Mouquet
bioRxiv 2022.04.01.486719; doi: https://doi.org/10.1101/2022.04.01.486719
Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Cyril Planchais, Ignacio Fernández, Timothée Bruel, Guilherme Dias de Melo, Matthieu Prot, Maxime Beretta, Pablo Guardado-Calvo, Jérémy Dufloo, Luis M. Molinos-Albert, Marija Backovic, Jeanne Chiaravalli, Emilie Giraud, Benjamin Vesin, Laurine Conquet, Ludivine Grzelak, Delphine Planas, Isabelle Staropoli, Florence Guivel-Benhassine, Mikaël Boullé, Minerva Cervantes-Gonzalez, French COVID Cohort Study Group, CORSER Study Group, Marie-Noëlle Ungeheuer, Pierre Charneau, Sylvie van der Werf, Fabrice Agou, Jordan D. Dimitrov, Etienne Simon-Lorière, Hervé Bourhy, Xavier Montagutelli, Félix A. Rey, Olivier Schwartz, Hugo Mouquet
bioRxiv 2022.04.01.486719; doi: https://doi.org/10.1101/2022.04.01.486719
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29195)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14179)
- Epidemiology (2067)
- Evolutionary Biology (18306)
- Genetics (12245)
- Genomics (16802)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60965)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)